Establishment of a bleeding risk model for low-molecular-weight heparin in cancer-associated venous thromboembolism: a single-center retrospective study
This study developed an optimized bleeding risk prediction model by enhancing the HAS-BLED score through the integration of three key variables: HAS-BLED score, LMWH dosage, and platelet count, demonstrating a robust application prospect for anticoagulation management in cancer patients.
Authors
- Changyu Ren
- Houfeng Zhou
- Z ZHANG (ORCID: https://orcid.org/0000-0002-3768-9839)
- Lankai Liao (ORCID: https://orcid.org/0000-0001-9806-7948)
Institutions
- Chengdu Fifth People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.3389/fphar.2025.1677891
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00